H. Pylori Treatment Insurance Denied? How to Appeal

Helicobacter pylori (H. pylori) is one of the most common bacterial infections worldwide, affecting an estimated 44% of the global population and causing the majority of peptic ulcers, a significant proportion of cases of chronic gastritis, and a measurable increase in gastric cancer risk. Effective eradication therapy exists and is well-supported by clinical guidelines. Yet insurance denials for H. pylori testing, antibiotic eradication therapy, and confirmatory post-treatment testing are surprisingly frequent. If your claim has been denied, understanding why and appealing with precise documentation can get your treatment covered.

Why Insurers Deny H. Pylori Claims

H. pylori denials occur across all three phases of management: initial testing, eradication therapy, and post-treatment confirmation.

Testing denied as not medically necessary. Insurers apply specific indications when evaluating whether H. pylori testing (urea breath test, CPT 83013/83014; stool antigen test, CPT 87338; endoscopic biopsy with CLO test, CPT 91110 + 87071) is covered. The American College of Gastroenterology (ACG) 2017 Clinical Guideline on H. pylori identifies clear test-and-treat indications: active or prior peptic ulcer disease (ICD-10 K25.x, K26.x), mucosa-associated lymphoid tissue (MALT) lymphoma (C88.4), following endoscopic resection of early gastric cancer, uninvestigated dyspepsia in adults, and functional dyspepsia. Some guidelines also support testing for unexplained iron deficiency anemia (D50.9) and immune thrombocytopenic purpura (D69.3). If your clinical indication is not clearly documented in the claim and physician notes, the insurer may deny testing.

Antibiotic combination not covered or not on formulary. First-line H. pylori eradication regimens require combination antibiotic therapy. Standard regimens include: triple therapy (PPI + clarithromycin + amoxicillin or metronidazole, 14 days), bismuth quadruple therapy (PPI + bismuth subsalicylate + tetracycline + metronidazole, 14 days), and concomitant therapy. If the specific antibiotic combination prescribed is not on the plan's formulary or requires Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization, individual components may be denied — even when the overall regimen is standard of care under ACG guidelines.

Confirmatory post-treatment testing denied. ACG guidelines recommend confirming H. pylori eradication at least 4 weeks after completing antibiotics and 2 weeks after stopping PPIs, using the urea breath test or stool antigen test (not serology). Insurers sometimes deny this confirmatory testing as duplicative or unnecessary when the initial treatment was completed, missing that eradication failure rates for first-line therapy range from 15% to 30%.

Prior authorization not obtained. Some plans require prior authorization for the urea breath test or for certain antibiotic combinations used in eradication regimens. A retroactive denial for missing prior authorization can often be overturned if the clinical urgency is documented or if provider error can be demonstrated.

Second-line or salvage regimens denied. When first-line therapy fails, salvage regimens — such as levofloxacin-based triple therapy or rifabutin-based therapy — are less familiar to payer reviewers and more likely to be denied as non-standard. These denials require direct citation of ACG guidelines and documentation of first-line failure confirmed by retesting.

How to Appeal an H. Pylori Treatment Denial

Step 1: Identify the exact reason for denial and the phase of management affected

The denial letter must state the specific basis for the denial. Determine whether the denial targets initial testing, the eradication antibiotic regimen, or post-treatment confirmation testing — as each requires a different appeal strategy. If the denial is for testing, focus on documenting the clinical indication. If the denial is for therapy, focus on formulary alternatives and clinical guideline support.

Step 2: Confirm accurate ICD-10 and CPT coding on the claim

Verify that the claim contains the appropriate ICD-10 diagnosis code: K25.x (gastric ulcer), K26.x (duodenal ulcer), K27.x (peptic ulcer), K29.7 (gastritis, unspecified), K30 (functional dyspepsia), or D50.9 (iron deficiency anemia, unspecified) for relevant indications. Confirm that the CPT codes match the test or treatment provided (83013 for UBT, 87338 for stool antigen, 87471 for H. pylori culture).

Step 3: Obtain a physician letter citing ACG guideline indications

Your gastroenterologist or primary care physician should provide a letter documenting your specific clinical indication for testing or treatment, citing the relevant ACG 2017 H. pylori guideline recommendation. For eradication therapy, the letter should confirm that the prescribed regimen is consistent with ACG first-line (or salvage, if applicable) recommendations and explain why any formulary alternative is clinically inappropriate for your specific case (e.g., clarithromycin resistance, penicillin allergy).

Step 4: Request formulary exception or step therapy exception for antibiotic denials

If the denial is based on formulary restrictions, request a formulary exception through your insurer's pharmacy benefit management process. Provide documentation from your physician that the denied antibiotic is required based on local antibiotic resistance patterns or patient-specific factors (allergy, prior treatment failure, drug interaction). Step therapy exceptions are also available under state step therapy laws in many states.

Step 5: Submit the internal appeal with complete clinical documentation

File your internal appeal within the deadline (typically 60–180 days from denial, depending on the plan). Include your physician's letter, the applicable ACG guideline excerpt, corrected ICD-10 and CPT codes if needed, and a clear written statement addressing the insurer's specific denial reason. Send by certified mail or through the insurer's secure portal and request confirmation of receipt.

Step 6: Request External Independent Review: Complete Guide" class="auto-link">external review or regulatory complaint if the internal appeal is denied

If the internal appeal fails, escalate to an independent review organization. For formulary denials, also consider filing a complaint with your state insurance commissioner, as step therapy and formulary exception requirements are regulated by state law in most states.

What to Include in Your Appeal

• Written denial letter from the insurer with the specific denial reason and criteria cited
• ICD-10 codes confirming your H. pylori indication (K25.x, K26.x, K30, D50.9, C88.4, or other applicable diagnosis)
• Physician letter citing ACG 2017 H. pylori Guideline and documenting the specific clinical indication, treatment choice rationale, and eradication failure data
• Test reports: positive urea breath test, stool antigen test result, or endoscopic biopsy pathology report confirming active H. pylori infection
• For antibiotic denials: formulary exception request with clinical justification, or documentation of prior treatment failure requiring salvage therapy

Fight Back With ClaimBack

H. pylori treatment denials are typically grounded in documentation gaps — an undercoded diagnosis, a missing clinical indication, or an unsupported formulary exception request. The ACG guidelines are clear and broadly recognized, which means a well-documented appeal citing those guidelines has strong grounds for reversal. ClaimBack helps you build a precise, clinically grounded appeal targeting the specific basis for your H. pylori denial. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal